Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
Jose Miguel Rivera-CaravacaIván J Núñez-GilDavid VivasMaría C Viana-LlamasAitor UribarriVíctor Manuel Becerra-MuñozDaniela TrabattoniInmaculada Fernández RozasGisela FeltesJavier López-PaisIbrahim El-BattrawyCarlos MacayaAntonio Fernandez-OrtizVicente EstradaFrancisco Marínnull nullPublished in: European journal of clinical investigation (2020)
Compared to patients without prior OAC, COVID-19 patients on OAC therapy at hospital admission showed lower survival and higher mortality risk. In these patients on OAC therapy, the prevalence of several comorbidities is high. Respiratory insufficiency and SIRS during hospitalization, as well as higher comorbidity, pointed out those anticoagulated patients with increased mortality risk.